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ABSTRACT
Zinc homeostasis is a highly regulated process in mammalian
cells that is critical for normal growth and development.
Movement of zinc across cell compartments is controlled by
two classes of transporters: Slc39a family members transport
zinc into the cytosol from either the extracellular space or
intracellular stores such as the endoplasmic reticulum (ER),
whereas the SLC30A family mediates zinc efflux from the
cytosol. In this study, we report that genetic ablation of
SLC39A7 (ZIP7) results in decreased cytosolic zinc levels,
increased ER zinc levels, impaired cell proliferation, and in-
duction of ER stress. Confirmatory of impaired zinc transport as
the causal mechanism, both the increased ER stress and
impaired cell proliferation were rescued by increasing cytosolic
zinc. Furthermore, using these robust cellular phenotypes, we
implemented a small-molecule library screen with 2800 com-
pounds and identified one small molecule capable of rescuing
ER stress and cell proliferation in ZIP7-deficient cells in the low
micromolar range.
Introduction
Zinc is an essential metal that is required for normal growth
and development in all higher plants and animals. Acting as a
cofactor for over 2000 proteins, zinc can modulate enzymatic
activity and gene transcription (Hogstrand et al., 2009), as
well as function as a second messenger in signaling pathways
(Yamasaki et al., 2007). Because zinc cannot freely permeate
lipid bilayers, active transport is required to move zinc across
cellular and organelle membranes. There are two families of
zinc transporters, categorized by their direction of zinc
movement. The solute carrier family 30A (SLC30A), also
known as the Zn transporter (ZnT) family, has 10 members
that mobilize zinc from the cytosol. The solute carrier family
39A (SLC39A) family, also known as the Zrt-, Irt-related
protein (ZIP) family, has 14 members that transport zinc into
the cytosol from the extracellular space or from intracellular
stores, such as the ER and Golgi. In addition to zinc, some
members of the ZIP family also transport iron (Pinilla-Tenas
et al., 2011), manganese (Girijashanker et al., 2008), and
cadmium (Fujishiro et al., 2012).
Recent publications have identified the importance of ZnT
and ZIP transporters in human health and disease. Mutations
in SLC39A8 cause intellectual disability with cortical atrophy
(Boycott et al., 2015); mutations in SLC39A14 (ZIP14) cause
childhood-onset parkinsonism-dystonia (Tuschl et al., 2016);
and mutations in SLC39A13 (ZIP13) cause a form of Ehlers–
Danlos syndrome (Giunta et al., 2008). Additionally, single-
nucleotide polymorphisms and copy number variations in
other ZnT and ZIP family members have been associated with
bipolar disorder (Baum et al., 2008), schizophrenia (Carrera
et al., 2012), autism (O’Roak et al., 2011; Gazzellone et al.,
2014), and other disorders (Kambe et al., 2015). Thus,
elucidating the function of individual zinc transporters may
help us understand the pathophysiology, treatment, and
prevention of zinc-related disease conditions.
ZIP7 is the only known ZIP family member that is localized
to the ER membrane and is hypothesized to be responsible for
mobilizing zinc from the ER, a zinc storage site, into the
cytosol (Taylor et al., 2004). ZIP7 is critical for normal growth
and development as the ZIP7 knockout (KO) is embryonic
lethal in mice, whereas loss-of-function mutations of the
drosophila ZIP7 homolog Catecholamines up (Catsup) lead
to abnormalwingdevelopment (Groth et al., 2013). Furthermore,
morpholino knockdown of ZIP7 expression in zebrafish causes
neurodevelopmental impairments, which can be rescued with
zinc supplementation (Yan et al., 2012). At the cellular level,
recent studies have illuminated a role for ZIP7 in the normal
function of the ER and shown that loss of ZIP7 results in ER
stress (Ohashi et al., 2016; Bin et al., 2017). However, the precise
mechanism of how loss of ZIP7 causes ER stress and affects zinc
levels has not been fully elucidated. In this work, we report
that clustered regularly interspaced short palindromic repeats
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(CRISPR)-mediated genetic ablation of ZIP7 in human cells
results in severely decreased levels of cytosolic zinc, impaired cell
proliferation, and activation of ER stress. Moreover, we demon-
strate the causality of the impaired cytosolic zinc levels by fully
rescuing both the impairment of cell proliferation and activation
of ER stress by restoring cytosolic zinc levels. Finally, we
implemented a small-molecule screen based on the ER stress
phenotype that yielded a lead compound with efficacy in fully
rescuing the effects of ZIP7 KO through a zinc-independent
mechanism.
Materials and Methods
Cell Culture and Genome Editing. MG-63 cells were grown
in Eagle’s minimum essential media supplemented with 10% fetal
bovine serum, 1 Pen/Strep, 1 non-essential amino acids, and 1
glutamine. Cells were split with trypsin every 3 to 4 days. MG-63 cells
were transfected with Lipofectamine 3000 (Thermofisher, Carlsbad,
CA) and SpCas9 plasmid with single guide RNA sequence: GCCA-
CACTCACGAGAGCATCTGG. This single guide RNA sequence tar-
gets exon 1 of SLC39A7. Seventy-two hours after transfection, green
fluorescent protein (GFP)–positive cells were sorted and plated at a
density of 5000 cells per 10-cm dish, such that single colonies could be
isolated. Clones were manually picked when colonies were ∼100 cells.
Colonies were expanded and screened for ZIP7 KO based on
disruption of DNA sequence and confirmed as KO by Western blot.
Cell lines were routinely checked to be free of mycoplasma infection
using Lonza MycoAlert Mycoplasma Detection Kit (LT07; Lonza,
Basel, Switzerland).
Western Blot. Cells were lysed using radioimmunoprecipitation
assay buffer (ThermoFisher) with protease (Sigma-Aldrich, St. Louis,
MO) and phosphatase (Pierce, Waltham, MA) inhibitors. After
centrifugation at 13,000g, protein concentration was measured using
the bicinchoninic acid protein assay kit (Pierce) and lysates were
separated on 4%–12% Bis–Tris gels (Invitrogen, Carlsbad, CA) using
4-morpholineethanesulfonic acid sodium dodecyl sulfate running buffer
(Invitrogen). Proteins were transferred with the iBlot system onto
nitrocellulose membranes (Novex, Thermofisher). Membranes were
blockedwith 5%milk (Sigma-Aldrich) and then incubated with primary
antibodies overnight at 4°C. Primary antibodies used were as follows:
SLC39A7 anti-rabbit (1:500, 117560; Abcam, Cambridge, UK) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-mouse
(1:1000, 374; EMD Millipore, Burlington, MA). Blots were visual-
ized using enhanced chemiluminescenceWestern blotting detection
reagents (Pierce).
Immunocytochemistry and Image Analysis. In each experi-
ment, cells were plated at a density of 1500 per well in 384-well Cell
Carrier Ultra microplates (PerkinElmer, Waltham, MA). Cells were
fixed with 4% paraformaldehyde at room temperature for 15 minutes,
followed by three washes with phosphate-buffered saline (PBS). Cells
were blocked in blocking buffer [5% BSA (Sigma-Aldrich) with 0.1%
Triton-X (Sigma-Aldrich) in PBS] for 1 hour at room temperature,
followed by primary antibody incubation in blocking buffer overnight
at 4°C. Cells were washed three times with PBS and then incubated
with secondary antibodies for 1 hour at room temperature diluted in
blocking buffer. Cells were washed three times with PBS and then
imaged on a PerkinElmer Opera Phenix. Primary antibodies used
were as follows: protein disulfide isomerase (PDI) anti-mouse (1:1000,
2792; Abcam), PDI anti-rabbit (1:1000, C81H6; Cell Signaling,
Danvers, MA), SLC39A7 anti-rabbit (1:500, 117560; Abcam), and
CCAAT enhancer-binding protein homologous protein (CHOP) anti-
mouse (1:3000, L63F7; Cell Signaling). HCS CellMask Deep Red Stain
(ThermoFisher) was used during the secondary antibody incubation
at 1:10,000 to identify the entire cell. To stain nuclei, NucBlue
(ThermoFisher) was used during the secondary antibody incubation
per the manufacturer instructions. Secondary antibodies used were as
follows: goat anti-rabbit Alexa Flour 488, goat anti-mouse Alexa Flour
488, and goat anti-rabbit Alexa Flour 568 all from ThermoFisher were
used at 1:500. In every experiment, five images per well were captured
at 20magnification, and each experiment was performed in triplicate
and repeated a minimum of three times. Images were analyzed using
Harmony Image Analysis System (PerkinElmer). Please see the
Supplemental Data for more detail on image analysis. GraphPad Prism
version 7was used to perform all statistical analysis. All statistical tests
were unpaired.
Phenotypic Screen. ZIP72/2 cells were plated at a density
of 1500 cells/well into 384-well Cell Carrier Ultra microplates
(PerkinElmer). Twenty-four hours after plating, cells were treated
with 1 mM compound. Pyrithione was used as the positive control at
500 nM. Cells were fixed with 4% paraformaldehyde 48 hours after
compound treatment. In the primary screen, cells were stained with
CHOP and HCS CellMask Deep Red Stain, as described above, and
the CHOP nucleus/cytoplasm ratio was calculated using Columbus
Image Analysis system. Hits were selected based on percentage of
inhibition of CHOP. Pyrithione was set as 100% inhibition, and hits
were determined based on 70% inhibition or above. In the secondary
screen, the 33 hits from the primary screen were retested at 1 mM in
triplicate for 48 hours. In the secondary screen, cells were stainedwith
CHOP,HCSCellMask, andPDI, as described above.Of the 33 primary
hits, 30 of them confirmed to inhibit CHOP in the secondary screen.
One compound (compound A) was identified to not only inhibit CHOP,
but also increased cell number and reduced PDI intensity and area.
Synthesis of Compound A. The synthesis of compound A is
described in U.S. Patent US2008/080081 in example 24 (Illig et al.,
2016).
Zinc Quantification by Inductively Coupled Plasma Mass
Spectrometry. Cells were plated in 10-cm dishes and were
harvested 72 hours after plating. Dishes were treated with either
vehicle (H2O) or 500 nM pyrithione. Equal number of cells was
fractionated to cytosol and ER fractions by first collecting cells and
spinning down at 300g. Supernatant was removed, and cells were
resuspended in sucrose buffer (0.32 M sucrose 1 10 mM HEPES).
Cells were homogenized by syringe-based homogenization. Next,
homogenized cells were spun at 300g for 10 minutes to remove nuclei.
Supernatant fromhomogenized cells was then centrifuged at 100,000g
for 1 hour. The supernatantwas removed and analyzed as the cytosolic
fraction. The pellet was resuspended in sucrose buffer and analyzed as
the microsome fraction that contains the ER. Zinc concentrations in
the cytosol and microsome fraction were determined by inductively
coupled plasmamass spectrometry (ICP-MS). Iridiumwas used as the
internal standard. Samples or standards were combined with
the internal standard, digested in 1% nitric acid, and then infused
into the ICP-MS for quantitation. Zinc concentrations were normal-
ized to the total number of cells.
RNA-Seq and Quantitative Polymerase Chain Reaction.
Total RNA from three biologic replicates per genotype was extracted
using the Qiagen RNeasy Mini Kit, according to the manufacturer’s
instructions. RNA sequencing (RNA-seq) and analysiswere performed
byNovogene (Beijing, China). Briefly, librarieswere constructed using
NEBNext UltraTM RNA Library Prep Kit following manufacturer’s
instructions, and polymerase chain reaction (PCR) products were
purified using AMPure XP System (Beckman Coulter, Brea, CA). The
library quality was assessed on the Agilent Bioanlyzer 2100 system.
The library was sequenced on an Illumina Hiseq platform. On
average, 65.8 million reads were obtained per sample. Raw reads
were processed through Novogene in-house scripts to obtain clean
reads, by removing reads containing adapters, reads containing
poly-N and low-quality reads. On average, 53 million clean reads
were obtained per sample. Readswere aligned to the reference genome
using TopHat v2.0.12; 89.84% of reads were uniquely mapped.
Fragments per kilobase of transcript per million mapped reads of
each gene were calculated based on the length of the gene and reads
mapped to each gene. Differential gene expression analysis was
performed using DESeq2 R package. The P values were adjusted
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using Benjamini and Hochberg’s method. Genes with an adjusted
P value ,0.05 were considered as differentially expressed. Gene
Ontology (GO) enrichment analysis was performed using GOseq,
based on Wallenius noncentral hypergeometric distribution.
For quantitative PCR, total RNA was extracted as described above.
RNAwas reverse transcribed into cDNA using Superscript III reverse
transcriptase (Invitrogen) with random hexamer primers. Transcript
abundance was determined by quantitative PCR using SYBR Green
PCRmix (Applied Biosystems, Foster City, CA). Transcripts were normal-
ized to GAPDH, and each sample was run in triplicate with three biologic
samples per genotype. SLC39A8 (ZIP8) forward, GGCCCCTTCAA-
ACAGGTACA and reverse, TGCTGTCACAGAAGCTAATGG; SLC39A14
(ZIP14) forward, GCAGCTTCATGGTGACTGAA and reverse, GCTAA-
GCTGCTTCTGCCG SLC30A1; ZNT1 forward, TCACCACTTCTGGGG-
TTTTC and reverse, ACCAGGAGGAGACCAACACC SLC30A5; ZNT5
forward, TTTGAAGGCTGTGGGACTTTTCG and reverse, GGTGTTTG-
GTAATAGTTTTCCCAG; GAPDH forward, AGGTCGGTGTGAACGG-
ATTTG and reverse, TGTAGACCATGTAGTTGAGGTCA.
Results
Generation and RNA-seq Analysis of ZIP7 KO Cells.
To elucidate the role of ZIP7 in human cells, we used CRISPR
genome editing (Shalem et al., 2014) to genetically ablateZIP7
from the osteosarcoma cell line, MG-63. MG-63 cells are large
cells that are ideal for imaging and amendable to transfection
and viral transduction.We identified two clones of 18 screened
that had indels in the first exon that introduce premature stop
codons. ZIP7 mRNA was significantly decreased in ZIP72/2
cells, consistent with nonsense-mediated decay. Moreover,
ZIP7 protein was undetectable by Western blot in ZIP72/2
clones (Fig. 1B). We next used ZIP71/1 and ZIP72/2 cells to
confirm the localization of ZIP7 to the ER, as has previously
been reported (Taylor et al., 2004; Bin et al., 2017). Immuno-
cytochemical labeling of ZIP71/1 cells with antibodies to the
ER-specific enzyme protein disulfide isomerase (PDI) and
ZIP7 confirmed strong colocalization of ZIP7 with PDI,
validating the localization of ZIP7 to the ER (Fig. 1A).
Importantly, ZIP7 staining was absent other than minimal
background labeling in ZIP72/2 cells, thereby confirming the
specificity of the ZIP7 antibody.
To investigate the function of ZIP7 in human cells, we
performed RNA-seq on ZIP71/1 and ZIP72/2 cells. There
were 6055 differentially expressed genes between ZIP71/1
and ZIP72/2 cells with an adjusted P value of ,0.05
(Fig. 1C), including upregulation of four zinc transporters.
Fig. 1. Generation and RNA-seq analysis of ZIP72/2 cells. (A) Representative images of ZIP7+/+ and ZIP72/2 cells stained with ZIP7 (green), PDI (red),
and 49,69-diamidino-2-phenylindole (blue). ZIP7+/+ cells show colocalization of ZIP7 with PDI. ZIP72/2 cells exhibit minimal background staining with
the ZIP7 antibody. (B)Western blot of ZIP7+/+ and ZIP72/2 cell lysates for ZIP7 and GAPDH expression. There is no detectable ZIP7 protein in ZIP72/2
clones. (C) Histographs of differentially expressed genes in ZIP72/2 cells. (D) Quantification of ZIP8, ZIP14, ZNT1, and ZNT5 in ZIP7+/+ and ZIP72/2
cells. Error bars represent S.E.M. (n = 4). Significant differences between ZIP7+/+ and ZIP72/2were determined by Student’s t test (**P, 0.01). (E) GO
analysis of ZIP7+/+ and ZIP72/2 cells. Protein processing in ER and cell cycle were the two significantly different pathways in ZIP7+/+ compared with
ZIP72/2.
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The transporters ZIP8, ZIP14, ZNT1, and ZNT5 all had a
twofold or greater upregulation in ZIP72/2 versus ZIP71/1
cells when measured by quantitative-PCR analysis (Fig. 1D).
To further identify cellular processes that were altered by
deletion of ZIP7, we performed GO analysis. GO analysis
revealed two significantly enriched categories, as follows: 1)
protein processing in the endoplasmic reticulum and 2)
cell cycle (Fig. 1E). These results are consistent with a
recent report that ZIP7 knockdown induces ER stress
genes and downregulates genes involved in the cell cycle
(Bin et al., 2017).
Loss of ZIP7 Causes Decreased Cell Proliferation
and ER Stress. To establish the RNA-seq hypothesized
functional consequences of ZIP7 KO, we first examined cell
proliferation. We plated equal numbers of ZIP71/1 and
ZIP72/2 cells and quantified the number of nuclei at 24, 48,
and 72 hours. ZIP71/1 cells more than doubled in number
during the 72-hour period, whereas the number of ZIP72/2
cells did not significantly increase (Fig. 2A).We next examined
whether ZIP72/2 cells exhibit ER stress as predicted by the
RNA-seq data by comparing the staining intensity of the ER
marker PDI in ZIP71/1 and ZIP72/2 cells (Fig. 2C). Indeed,
ZIP72/2 cells exhibited significantly increased intensity of
PDI (Fig. 2B), consistent with ER stress (Ko et al., 2002).
Moreover, in addition to the increase of PDI intensity, we also
observed a parallel increase of the area of PDI staining in
ZIP72/2 cells. Specifically, we quantified the area of PDI
staining as a proportion of the cytoplasmic area, which
confirmed a significant expansion of the PDI-labeled ER in
ZIP72/2 cells (Fig. 2D), again consistent with ER stress. To
further evaluate this possibility, we also examined the
localization of CHOP, a transcription factor that is localized
to the cytoplasmunder normal conditions, but translocates to the
nucleus under conditions of ER stress (Ron and Habener, 1992).
Consistent with ER stress, ZIP72/2 cells exhibited strong
nuclear localization of CHOP in contrast to ZIP71/1 cells (Fig.
2, E and F). Taken together, based on the increased intensity of
PDI labeling, expansion of PDI-labeled ER area, and nuclear
localization of CHOP, there is substantial evidence to suggest
that ZIP72/2 cells have increased ER stress.
Wild-Type ZIP7 Rescues Proliferation and ER Stress
Phenotypes. To confirm that both the cell proliferation and
ER stress phenotypes are dependent on ZIP7, we infected cells
with lentivirus to overexpress either GFP, wild-type (WT)
ZIP7, or a previously reported loss-of-function ZIP7G178D
mutant (Groth et al., 2013). Overexpression of WT ZIP7 in
ZIP72/2 cells rescued cell proliferation, compared with trans-
duction with GFP or ZIP7G178D (Fig. 3, A and B). WT ZIP7
expression also rescued ER stress, with a decrease in the
CHOP nucleus/cytoplasmic ratio, PDI intensity, and PDI area
(Fig. 3, C–E) compared with GFP or ZIP7G178D transduced
cells (Fig. 3, C–E). These results conclusively demonstrate
that loss of ZIP7 results in decreased cell proliferation and
induction of ER stress.
ZIP7 Is Essential for Regulation of Cytosolic Zinc
Levels. The ER is a site of zinc storage, and it has been
hypothesized that ZIP7 transports zinc into the cytoplasm
from the ER stores (Taylor et al., 2008). However, whether loss
of ZIP7 affects ER or cytosolic zinc levels has never been
conclusively demonstrated. Given our confirmation of earlier
studies demonstrating that ZIP7 is localized to the ER (Fig. 1),
we sought to measure zinc concentrations in the ER and
cytosol using subcellular fractionation of ZIP71/1 and
ZIP72/2 cells. Specifically, we measured zinc concentrations
in the respective ER and cytosolic fractions using inductively
coupled plasmamass spectrometry (ICP-MS). Consistent with
previous reports inWT cells (Qin et al., 2011; Sun et al., 2015),
we observed that the zinc concentration in the cytoplasmic
Fig. 2. ZIP7 KO causes decreased proliferation and induction of ER stress. (A) Quantification of cell number in ZIP7+/+ and ZIP72/2 cells after 24, 48,
and 72 hours. There are significantly less ZIP72/2 cells compared with ZIP7+/+ cells, 48 and 72 hours after plating. (B) Quantification of PDI intensity in
ZIP7+/+ and ZIP72/2 cells. There is a significant increase in PDI intensity in ZIP72/2 relative to ZIP7+/+ cells. Values are expressed as a fold change in
intensity relative toZIP7+/+ cells. (C) Representative images ofZIP7+/+ andZIP72/2 cells. PDI (green) andCellMask (red). (D) Quantification of ER area
in ZIP7+/+ and ZIP72/2 cells. There is a significant increase in the ER area in ZIP72/2 cells compared with ZIP7+/+ cells. (E) Quantification of CHOP in
the nucleus versus the cytoplasm in ZIP7+/+ and ZIP72/2 cells. There is a significant increase in CHOP in the nucleus versus the cytoplasm in ZIP72/2
cells compared with ZIP7+/+ cells. (F) Representative images of ZIP7+/+ and ZIP72/2 cells stained with CHOP (green). Error bars represent S.E.M. from
three independent experiments (n = 3). Significant differences between ZIP7+/+ and ZIP72/2 cells were determined by Student’s t test (**P , 0.01).
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fraction (∼1400 ng/ml) was significantly higher than zinc
levels in the ER fraction (∼500 ng/ml) (Fig. 4). In contrast,
ZIP72/2 cells exhibited a significant increase of ER zinc
concentration and decrease of cytosolic zinc concentration
(Fig. 4). These results are consistent with a model whereby
ZIP7 transports zinc from the ER into the cytosol, for which
loss of ZIP7 results in a shift of the equilibrium toward an
increased ER zinc concentration. Therefore, to directly test
this hypothesis, we treated cells with pyrithione, an ionophore
that transports zinc through the cell membrane. Indeed, when
ZIP72/2 cells were treated with 500 nM pyrithione, cytosolic
zinc levels were significantly increased comparedwith vehicle,
nearly reaching the concentration observed in ZIP71/1 cells
(Fig. 4). This was presumably due to pyrithione’s ability to
shuttle the free zinc present in fetal bovine serum (a compo-
nent of the media) into the cells. We did not observe any
changes in ER zinc in these cells, confirming that the
increased ER zinc concentration in ZIP72/2 cells results from
an inability to transport zinc out of the ER, rather than a
cytoplasmic impairment due to the increased concentration of
cytosolic zinc (Fig. 4). Therefore, ZIP7 is essential for main-
taining both ER and cytosolic zinc levels.
Cell Proliferation and ER Stress Are Rescued by
Restoring Cytosolic Zinc. Given our observation that
treating ZIP72/2 cells with pyrithione can largely restore
cytosolic zinc levels, we next asked whether this was sufficient
to rescue the cell proliferation and ER stress phenotypes.
Importantly, given that pyrithione rescued the abnormal
cytosolic, but not ER, concentration of zinc in ZIP72/2 cells
(Fig. 4), this also provided us the opportunity to gaugewhether
the cell proliferation and ER stress phenotypes are driven by
cytoplasmic or ER zinc concentrations. ZIP72/2 cells were
treated with pyrithione for 72 hours, followed by quantifica-
tion of nuclei density, PDI intensity, PDI area, and CHOP
Fig. 3. Overexpression of WT ZIP7 rescues cell proliferation and ER stress phenotypes. (A) Representative images of ZIP72/2 cells either untransduced
or transduced with GFP, WT ZIP7, or ZIP7G178D for 72 hours and stained with PDI (orange). (B) Quantification of cell number after 72 hours of
transduction. WT ZIP7 significantly increased cell number compared with untransduced cells. There were no significant differences in ZIP7 G178D-
transduced cells. (C) Quantification of nuclear/cytoplasmic CHOP after 72 hours of transduction. Translocation of CHOP was significantly decreased in
cells transduced with WT ZIP7 compared with untransduced cells. (D) Quantification of PDI intensity 72 hours after virus transduction. PDI intensity
was significantly decreased in WT ZIP7-transduced cells. (E) Quantification of ER area. ER area was significantly decreased in WT ZIP7-transduced
cells. Error bars represent S.E.M. from three independent experiments (n = 3). Significant differences were determined by one-way analysis of variance,
followed by Dunnett’s test (**P , 0.01).
Fig. 4. ZIP7 KO causes reduced zinc in the cytoplasm and increased zinc in the ER. (A) ER concentrations of zinc from ZIP7+/+ and ZIP72/2 cells with
vehicle and 500 nM pyrithione treatment. ZIP72/2 cells exhibit significantly increased ER zinc levels compared with ZIP7+/+ cells with vehicle
treatment. ER zinc levels are not significantly changed with pyrithione treatment. (B) Cytosol concentrations of zinc fromZIP7+/+ andZIP72/2 cells with
vehicle and 500 nM pyrithione treatment. ZIP72/2 cells have significantly decreased cytosol zinc levels compared with ZIP7+/+ cells. Error bars
represent S.E.M. (n = 6). Significant differences between vehicle- and pyrithione-treated cells were determined by Student’s t test (**P , 0.01).
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nuclear/cytoplasmic ratio. Treatment with pyrithione induced
significantly increased proliferation within 72 hours (Fig. 5B).
Moreover, pyrthione treatment also resulted in significantly
decreased PDI intensity, PDI area, and nuclear localization of
CHOP (Fig. 5, A and C-E). Together, these findings establish
the causality of decreased cytosolic zinc levels in mediating
the impaired cell proliferation and induction of ER stress in
ZIP72/2 cells.
Phenotypic Drug Screen in ZIP72/2 Cells. Phenotypic
drug screening is a powerful tool to identify compounds that
affect a given cellular phenotype. Such screening functions in
a target-agnostic manner and has the possibility of uncovering
novel biology. We performed a small-scale drug screen with
2816 internal kinase inhibitor compounds at a concentration
of 1 mM to search for compounds that alleviate ER stress in
ZIP2/2 cells using the nuclear translocation of CHOP as a
readout. We used pyrithione treatment as a positive control
and selected compounds with at least 70% inhibition of CHOP
translocation compared with the positive control. Based on
these criteria, we identified 33 compound hits. To confirm the
hits, we performed a secondary screen in triplicate inwhichwe
also quantified cell number, PDI intensity, and PDI area. Of the
33 initial hits, 30 were confirmed to inhibit CHOP transloca-
tion when tested in triplicate. Interestingly, we identified one
compound (compound A) that significantly inhibited CHOP
translocation, increased cell number, and decreased PDI in-
tensity and area (Fig. 6, D–G). We tested compound A in dose
response and only found an effect at 1mM (Supplemental Fig. 1).
The structure of compound A (4-cyano-N-[2-(4,4-dimethylcyclo-
hex-1-en-1-yl)-4-(2,2,6,6-tetramethyl-1,1-dioxidotetrahydro-
2H-thiopyran-4-yl)phenyl]-1H-imidazole-2-carboxamide) is
shown in Fig. 6C. Compound A was identified internally as
an inhibitor of CSF1R with an IC50 of ∼3 nM (data not
shown). However, compound A is not rescuing the ZIP72/2
phenotypes in a CSF1R-dependent manner because ZIP72/2
cells do not express CSF1R (data not shown). Additionally,
other CSF1R inhibitors were present in the screening
library but did not rescue the ZIP72/2 phenotypes (data
not shown). We also tested compound A in ZIP71/1 cells
and observed that compound A does not have any effect on
proliferation or ER stress in ZIP71/1 cells (Supplemental
Fig. 2). This result demonstrates that compound A is
specific for rescuing phenotypes associated with loss of
ZIP7. To test whether compound A is an inhibitor of other
kinases, we performed the Eurofins kinase selectivity panel
(1 mM) and found that compound A inhibits many other
kinases. However, of those kinases, ZIP72/2 cells only
express JAK1, PDK1, PLK4, STK16, and TYK2 (Supple-
mental Table 1). When we tested whether commercially
available inhibitors of those kinases could rescue ZIP72/2
phenotypes, none had any significant impact on cell
number, CHOP translocation, PDI intensity, or PDI
area. Thus, compound A is rescuing ZIP72/2 phenotypes
through a mechanism other than CSF1R, JAK1, PDK1,
PLK4, STK16, or TYK2 inhibition.
Lastly, to examine whether the mechanism of action by
which compound A rescued the cellular phenotypes was zinc-
dependent, we treated ZIP72/2 cells with compound A and
measured cellular zinc levels by ICP-MS. We found no
significant differences in cytosolic or ER zinc concentrations
when cells were treated with compound A (Fig. 7, A and B).
This result demonstrates that ER stress and proliferation
caused by ZIP7 ablation can be rescued by zinc-independent
mechanisms. We also tested whether compound A could block
ER stress induced by tunicamycin, brefeldin A, or thapsigar-
gin. We treated ZIP71/1 cells with compound A and found no
Fig. 5. Pyrithione treatment rescues ER stress and proliferation in ZIP72/2 cells. (A) Representative images of ZIP72/2 cells treated with vehicle or
pyrithione for 72 hours. Cells were stainedwith CHOP (green) and PDI (orange). (B) Quantification of cell number in vehicle- and pyrithione-treated cells.
(C) Quantification of CHOP in the nucleus versus the cytoplasm in vehicle- and pyrithione-treated cells. (D) Quantification of PDI intensity in vehicle- and
pyrithione-treated cells. Values are expressed as fold change relative to vehicle. (E) Quantification of ER area in vehicle- and pyrithione-treated cells.
Values are expressed as fold change relative to vehicle. In all graphs, error bars represent S.E.M. from three independent experiments (n = 3). Significant
differences between vehicle- and pyrithione-treated cells were determined by Student’s t test (**P , 0.01).
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significant differences in the CHOP nucleus/cytoplasmic ratio
(Fig. 7C). Treating ZIP71/1 cells with tunicamycin, brefeldin
A, and thapsigargin induced CHOP translocation to the
nucleus (Fig. 7C). Interestingly, compound A failed to block
CHOP translocation induced by tunicamycin, brefeldin A, or
thapsigargin (Fig. 7C). These results demonstrate that com-
pound A may be specific for rescuing ER stress only when ER
stress is induced by low cytosolic zinc.
Fig. 6. Phenotypic screen for small molecules that rescue ER stress and proliferation in ZIP72/2 cells. (A) Schematic of screening results. Two thousand
eight hundred and sixteen small molecules were screened at a concentration of 1 mM. There were 33 primary hits that inhibit CHOP translocation to the
nucleus, and 30 of those were confirmed in the secondary screen. One compound was identified to rescue all ZIP72/2 phenotypes, including cell number,
PDI intensity, and ER area. (B) Representative images of vehicle and compounds that rescue CHOP nuclear translocation, PDI intensity, and PDI area.
Cells are stained with CHOP (green) and PDI (orange). (C) Structures of compound A. (D) Quantification of cell number in vehicle- and compound-treated
cells. (E) Quantification of CHOP in the nucleus versus the cytosol. Values are expressed as relative to vehicle. (F) Quantification of PDI intensity in
vehicle- and compound-treated cells. Values are expressed as relative to vehicle. (G) Quantification of ER area in vehicle- and compound-treated cells.
Values are expressed as relative to vehicle. Error bars in all graphs represent S.E.M. from three independent experiments (n = 3). Significant differences
between vehicle- and compound-treated cells were determined by Student’s t test (**P , 0.01).
Fig. 7. Compound A rescues ZIP72/2 phenotypes independent of zinc levels. (A) Quantification of cytosolic zinc concentration by ICP-MS. Compound A
does not significantly alter cytosolic zinc levels. (B) Quantification of ER zinc levels by ICP-MS. Compound A does not significantly alter ER zinc levels.
Error bars represent S.E.M. from three biologic replicates. (C) Quantification of CHOP in the nucleus versus the cytosol in cells treated with inducers of
ER stress. Tunicamycin, brefeldin A, and thapsigargin induce CHOP translocation to the nucleus, and compound A does not block the CHOP
translocation. Significant differences between vehicle and ER stress inducer were determined by one-way analysis of variance, followed by Dunnett’s test
(**P, 0.01). There were no significant differences betweenER stress inducer–treated cells versus ER stress inducer and compoundA–treated cells. Error
bars represent S.E.M. from three independent experiments (n = 3). ns, not significant.
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Discussion
In this study, we investigated the role of ZIP7 in the regulation
of cellular zinc levels. We found that CRISPR/Cas9-mediated
ablation of ZIP7 results in significantly decreased zinc concen-
tration in the cytosol and increased zinc levels in the ER, with
concomitant abnormalities in cell proliferation and ER stress.
Both phenotypes are rescued when ZIP7 is overexpressed or
when cytosolic zinc levels are restored with pyrithione. Addi-
tionally, we identified a small molecule that completely rescues
the phenotypic effects of ZIP7 KO by a zinc-independent
mechanism, which might have important implications for treat-
ing diseases of aberrant zinc homeostasis.
Zinc has a well-established role as a frequent cofactor in
enzyme catalysis and protein folding (Andreini et al., 2011;
Andreini and Bertini, 2012). More recently, zinc also has a
proposed role as a second messenger for intracellular signal-
ing and transduction pathways. Thus, establishing how cyto-
solic zinc levels are regulated is important for understanding
how cells maintain a variety of critical functions. In this study,
we definitively demonstrate that ZIP7 is essential for main-
tenance of cytosolic zinc levels. Even though we observed
upregulation of other zinc transporters in ZIP72/2 cells, these
changes were not sufficient to compensate for the loss of ZIP7.
This suggests that ZIP7 is obligatory for maintaining cytosolic
zinc. Furthermore, we show that insufficient zinc levels in the
cytosol impair cell proliferation and induce ER stress. Treat-
ment of ZIP72/2 cells with pyrithione rescued ER stress
phenotypes, but notably only with restoration of cytosolic zinc
levels and without any evidence of a restored ER zinc
concentration. Previous studies hypothesized that accumula-
tion of zinc in the ER was the cause of ER stress in ZIP7
deficiency (Bin et al., 2017), but based on the selective rescue
of cytosolic, but not ER, zinc by pyrithione, our findings
indicate that low cytosolic zinc was the driver of both ER
stress and proliferation defects. Bin et al. (2017) hypothesized
that elevated zinc in the ER causes PDI to aggregate, which
prevents the proper folding of proteins and ultimately leads to
ER stress. Therefore, although our results demonstrate that
low levels of zinc in the cytosol are the cause of ER stress, we
cannot rule out that altered activity of PDI might also be a
contributing factor.
ZIP7 is one of the 10% of genes that are consistently
upregulated in breast cancer (Hogstrand et al., 2009). Our
results suggest that increased expression of ZIP7 could cause
growth advantages, possibly by increasing zinc levels in the
cytosol. Thus, targeting intracellular zinc levels could be of
therapeutic benefit in breast cancer. One way to modulate
intracellular zinc would be to identify modulators of ZIP
transporters that reside on the cell surface. Our results
suggest that intracellular zinc levels need to be carefully
fine-tuned as low intracellular zinc causes growth retardation,
for which increased cytosolic zinc may lead to a growth
advantage.
To date there are numerous reports of mutations in ZnT and
ZIP transporters that cause disease and dozens of single-
nucleotide polymorphisms that may contribute to an array of
medical conditions. Presumably these mutations are causing
aberrant zinc or other metal homeostasis, which highlights
the need for therapies that can compensate for changes in zinc
transporter activity or function; however, this remains to
be systemically evaluated. In our study, we identified a
compound that completely rescues the proliferation and ER
stress consequences of ZIP7 KO, which validates that disor-
ders of zinc homeostasis can be therapeutically targeted.
Moreover, given that the compound that we identified rescues
ER stress and proliferation without changing zinc levels,
phenotypes caused by aberrant metal homeostasis appear to
be possible to rescue by zinc-independentmechanisms. Future
studies to elucidate both the zinc-dependent and zinc-
independent mechanisms hold therapeutic potential for treat-
ing disease caused by zinc imbalances.
In conclusion, we propose that ZIP7 is an essential regulator
of cytosolic zinc levels and that sufficient levels of zinc in the
cytosol are necessary for normal proliferation and normal ER
function. ZIP7 could be a therapeutic target for conditions in
which zinc levels are dysregulated or in conditions of high ER
stress.
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